Sign In
Buy GNLX
$2.95
-0.0200 (-0.673%)
At Close: Jun 02, 2026
Genelux: Recent IPO With Phase 3 Stage Oncolytic Virus Cancer Therapy
10:50pm, Sunday, 26'th Mar 2023
GNLX IPO-ed recently, but the company has been around for two decades. The company develops an oncolytic virus targeting cancer.
5 Best and Worst Performing Small-Cap Stocks in February 2023
10:51pm, Monday, 13'th Mar 2023
Small-cap stocks, in general, are more domestic in nature, and this protects them from geopolitical and foreign exchange risks.
Hot Stocks And Hot Wings Serve Up Spicy Breakouts And Buy Zones
08:00am, Wednesday, 08'th Mar 2023
As the market indexes fight for support, ANET, WING, BKNG, CDNS, PANW and more land a spot on the IBD Breakout Stocks Index. The post Hot Stocks And Hot Wings Serve Up Spicy Breakouts And Buy Zones ap
Genelux IPO prices at bottom of range
06:40am, Thursday, 26'th Jan 2023
Genelux Corp. priced its initial public offering at $6 a share, the low end of its $6 to $7 a share range, for its stock market debut Thursday on the Nasdaq under the symbol GNLX. With 2.5 million sha
